Drug improves disease-free, overall survival after hematopoietic stem cell transplants – News-Medical.net
|
Drug improves disease-free, overall survival after hematopoietic stem cell transplants
News-Medical.net Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening severe acute graft … |
